Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model
暂无分享,去创建一个
Qianbin Li | Gaoyun Hu | Liqing Hu | Congke Zhao | Xiangyang Le | Mengqi Li | Yuanbo Hu | Xiaohui Li | Zhuo Chen
[1] Qinglian Liu,et al. A first-in-class inhibitor of Hsp110 molecular chaperones of pathogenic fungi , 2023, Nature communications.
[2] Qianbin Li,et al. Pulmonary artery smooth muscle cell phenotypic switching: A key event in the early stage of pulmonary artery hypertension. , 2023, Drug discovery today.
[3] D. Pascual,et al. Comentarios a la guía ESC/ERS 2022 sobre el diagnóstico y tratamiento de la hipertensión pulmonar , 2023, Revista Española de Cardiología.
[4] C. Garrido,et al. Discovery of second generation heat shock protein 110 (HSP110) inhibitors for potential treatment of colorectal cancer , 2023, European Journal of Medicinal Chemistry Reports.
[5] D. Pascual,et al. Comments to the 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. , 2022, Revista espanola de cardiologia.
[6] Wei Chen,et al. Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway , 2022, Respiratory Research.
[7] Qianbin Li,et al. TPN171H alleviates pulmonary hypertension via inhibiting inflammation in hypoxia and monocrotaline-induced rats. , 2022, Vascular pharmacology.
[8] Kun Sun,et al. Caspase-4/11–Mediated Pulmonary Artery Endothelial Cell Pyroptosis Contributes to Pulmonary Arterial Hypertension , 2022, Hypertension.
[9] Qianbin Li,et al. An emerging strategy for targeted therapy of pulmonary arterial hypertension: vasodilation plus vascular remodeling inhibition. , 2022, Drug discovery today.
[10] L. Farkas,et al. Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension , 2021, International journal of molecular sciences.
[11] Lijun Li,et al. Novel Pyrazolo[3,4-b] Pyridine Derivative (HLQ2g) Attenuates Hypoxic Pulmonary Hypertension via Restoring cGKI Expression and BMP Signaling Pathway , 2021, Frontiers in Pharmacology.
[12] Qinglian Liu,et al. Interdomain interactions dictate the function of the Candida albicans Hsp110 protein Msi3 , 2021, The Journal of biological chemistry.
[13] Qinglian Liu,et al. Purification and biochemical characterization of Msi3, an essential Hsp110 molecular chaperone in Candida albicans , 2021, Cell Stress and Chaperones.
[14] Lei Wang,et al. Targeting the HSP90–CDC37–kinase chaperone cycle: A promising therapeutic strategy for cancer , 2021, Medicinal research reviews.
[15] Xiangrui Jiang,et al. Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives. , 2020, Journal of medicinal chemistry.
[16] J. Ryan,et al. Management of Pulmonary Arterial Hypertension , 2020, Current Cardiovascular Risk Reports.
[17] Qinglian Liu,et al. Discovery of Novel Pyrazolo[3,4-b] pyridine Derivatives with Dual Activities of Vascular Remodeling Inhibition and Vasodilation for the Treatment of Pulmonary Arterial Hypertension. , 2020, Journal of medicinal chemistry.
[18] Qianbin Li,et al. Discovery of a Dual Tubulin Polymerization and Cell Division Cycle 20 Homologue Inhibitor via Structural Modification on Apcin. , 2020, Journal of medicinal chemistry.
[19] Li Li,et al. Heat shock protein 90 (Hsp90) Inhibitors: An Update on Achievements, Challenges, and Future Directions. , 2020, Journal of medicinal chemistry.
[20] S. Rosenkranz,et al. Current and future treatments of pulmonary arterial hypertension , 2020, British journal of pharmacology.
[21] Lei Wang,et al. Modulation of protein fate decision by small molecules: targeting molecular chaperone machinery , 2020, Acta pharmaceutica Sinica. B.
[22] C. Garrido,et al. Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy , 2019, Cancers.
[23] R. Rafikov,et al. Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development , 2019, Antioxidants & redox signaling.
[24] Yanqing Ding,et al. KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis , 2019, Oncogene.
[25] Jian Zhang,et al. Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer , 2019, Science Advances.
[26] D. Mould,et al. Pharmacokinetic and Pharmacodynamic Effects of Oral CXA‐10, a Nitro Fatty Acid, After Single and Multiple Ascending Doses in Healthy and Obese Subjects , 2019, Clinical and translational science.
[27] O. Demidov,et al. Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy , 2019, Cell Death & Differentiation.
[28] I. Rahman,et al. Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the Population Assessment of Tobacco and Health (PATH) study, wave 2 , 2019, Tobacco Control.
[29] J. Wang,et al. HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling. , 2019, Vascular pharmacology.
[30] Paul G. Williams,et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.
[31] D. Altieri,et al. Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension , 2018, American journal of respiratory and critical care medicine.
[32] S. Archer,et al. Pulmonary arterial hypertension: pathogenesis and clinical management , 2018, British Medical Journal.
[33] O. Demidov,et al. HSP110 promotes colorectal cancer growth through STAT3 activation , 2017, Oncogene.
[34] H. Palevsky,et al. Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double‐Blind, Placebo‐controlled Trial , 2016, American journal of respiratory and critical care medicine.
[35] W. Seeger,et al. Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension , 2016, European Respiratory Journal.
[36] M. Gladwin,et al. Strategies to increase nitric oxide signalling in cardiovascular disease , 2015, Nature Reviews Drug Discovery.
[37] C. Tripodo,et al. HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma. , 2015, Blood.
[38] Yibing Yan,et al. HSP105 Recruits Protein Phosphatase 2A To Dephosphorylate β-Catenin , 2015, Molecular and Cellular Biology.
[39] M. Humbert,et al. Pathogenesis of pulmonary arterial hypertension: lessons from cancer , 2013, European Respiratory Review.
[40] M. Humbert,et al. Pulmonary arterial hypertension , 2013, Orphanet Journal of Rare Diseases.
[41] Andrija Finka,et al. Hsp110 Is a Bona Fide Chaperone Using ATP to Unfold Stable Misfolded Polypeptides and Reciprocally Collaborate with Hsp70 to Solubilize Protein Aggregates* , 2013, The Journal of Biological Chemistry.
[42] Nadinath B. Nillegoda,et al. Metazoan Hsp70 machines use Hsp110 to power protein disaggregation , 2012, The EMBO journal.
[43] C. Tournigand,et al. Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis , 2011, Nature Medicine.
[44] H. Ghofrani,et al. Mechanisms of disease: pulmonary arterial hypertension , 2011, Nature Reviews Cardiology.
[45] S. Erzurum,et al. Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension. , 2010, Comprehensive Physiology.
[46] J. Pelletier,et al. Target identification using drug affinity responsive target stability (DARTS) , 2009, Proceedings of the National Academy of Sciences.
[47] J. Michálek,et al. Significant overexpression of Hsp110 gene during colorectal cancer progression. , 2009, Oncology reports.
[48] M. Hoeper,et al. Endothelin receptor antagonists in pulmonary arterial hypertension , 2008, European Respiratory Journal.
[49] R. Barst,et al. Prostanoid therapy for pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[50] D. Easton,et al. The Chaperoning Activity of hsp110 , 1999, The Journal of Biological Chemistry.
[51] Chunhua Zhang,et al. Drug Affinity Responsive Target Stability (DARTS ) Assay to Detect Interaction Between a Purified Protein and a Small Molecule. , 2021, Methods in molecular biology.